Search

Your search keyword '"Matthias Heck"' showing total 148 results

Search Constraints

Start Over You searched for: Author "Matthias Heck" Remove constraint Author: "Matthias Heck"
148 results on '"Matthias Heck"'

Search Results

1. Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ('Oligometastatic') and M2 ('Polymetastatic') subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)

2. Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer

4. Current Staging Procedures in Urinary Bladder Cancer

5. Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)

8. Ultrasound-based 'CEUS-Bosniak'classification for cystic renal lesions: an 8-year clinical experience

9. Tough PEGgels by In Situ Phase Separation for 4D Printing

10. Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus

11. Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study

12. Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

13. PSMA-PET/CT–based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy

14. [99mTc]Tc-PSMA-I&S: Anwendung zur Radioguided Surgery beim rezidivierten Prostatakarzinom

15. PSMA-Theranostik beim Prostatakarzinom

16. Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma

17. Early Prostate-Specific Antigen Changes and Clinical Outcome After 177Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

18. Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis

19. Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?

20. One-Pot Synthesis of Alternating (Ultra-High Molecular Weight) Multiblock Copolymers via a Combination of Anionic Polymerization and Polycondensation

21. MP11-12 REGIONAL LYMPH NODE METASTASIS ON PSMA PET CORRELATES WITH DECREASED BCR-FREE AND THERAPY-FREE SURVIVAL AFTER RADICAL PROSTATECTOMY

22. Extended Lymph Node Dissection for Bladder Cancer: Do Clinical Trials Rule Out a Benefit?

23. Automatic detection of avalanches combining array classification and localization

24. Molekulares Tumorboard Prostatakarzinom

25. Cohort study of patients with oligorecurrent prostate cancer: Oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery

26. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy

27. Adenomatous hyperplasia induced by chronic cherry pit retention mimicking an endobronchial tumor-case series and systematic review of literature

28. Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study

30. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

31. The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series

32. Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis

33. Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer

34. Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer

35. Minimally invasive versus open cytoreductive nephrectomy for primary metastatic renal cancer: A multi-institutional experience from the REMARCC registry

36. Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer

37. MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE

38. Cohort study of oligorecurrent prostate cancer patients: Oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery

39. Early Experience of Rechallenge 177Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate Cancer

40. Transitions between Lamellar Orientations in Shear Flow

41. Efficacy, Predictive Factors, and Prediction Nomograms for 68 Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy

42. Automatic detection of snow avalanches in continuous seismic data using hidden Markov models

43. Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy

44. AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide

45. Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry

46. Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages

47. Forecasting snow avalanches using avalanche activity data obtained through seismic monitoring

48. Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection

49. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer

50. Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?

Catalog

Books, media, physical & digital resources